Gene · 28906
IGKV6-21: immunoglobulin kappa variable 6-21 (non-functional)
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. IGKV6-21: immunoglobulin kappa variable 6-21 (non-functional). Genes, record 28906. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/28906
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| A0A0C4DH24 | Immunoglobulin kappa variable 6-21 | 114 | 0 | Ensembl, HGNC |
Source UniProt
Patents6
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 10724 | A0A0C4DH24 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 10724 | A0A0C4DH24 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 39872 | A0A0C4DH24 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 39873 | A0A0C4DH24 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 142843 | A0A0C4DH24 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 142844 | A0A0C4DH24 | Espacenet |
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants656
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | IGKV6-21 papers | Newest fiscal year |
|---|---|---|---|
| P30CA013148 | Comprehensive Cancer Center Support Grant | 8 | 2025 |
| P30AI027767 | UAB Center for AIDS Research (CFAR) | 6 | 2025 |
| P30CA138313 | Medical University of South Carolina - Cancer Center Support Grant | 4 | 2025 |
| P30DK123704 | MUSC Digestive Disease Research Core Center | 4 | 2025 |
| R01GM130091 | Quantitative Characterization of Glycopeptide Isomers | 4 | 2025 |
| T32GM132055 | Cellular, Biochemical and Molecular Sciences Training Program | 4 | 2025 |
| ZIAAI000986 | Influenza Viral Pathogenesis | 4 | 2025 |
| P01HL151333 | Molecular and Clinical Glycobiology of the Bone Marrow Environment | 3 | 2025 |
| R01CA160254 | Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach | 3 | 2025 |
| R01GM115234 | Regulatory Mechanisms of Glycoprotein Sialylation | 3 | 2025 |
1 to 10 of 656Source NIH's project files
See all 656 nih grantsPapers1,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ST6GAL1 promotes cancer stem-like cell-associated paclitaxel resistance through the EGFR-mTOR-SOX2/BMI1 axis in non-small cell lung cancer. | Cancer Drug Resist | 2026 | 42764906 | PubTator, text mining | PubMed |
| ST6GAL1-mediated sialyl linkage switching drives cancer-promoting α2,6-sialo-protrusions radiating from anti-inflammatory TAMs. | Proc Natl Acad Sci U S A | 2026 | 42640786 | PubTator, text mining | PubMed |
| Programmable One-Tube Sialic Acid Derivatization Enables Dual-Mode N-Glycomics of Low-Input Samples. | Anal Chem | 2026 | 42578856 | PubTator, text mining | PubMed |
| Sialic Acid Linkage-Specific Alkylamidation-Based Method for N- and O-Glycoproteomic Profiling of Human Plasma. | Anal Chem | 2026 | 42421262 | PubTator, text mining | PubMed |
| Bioorthogonal labeling of sialic acid isomers for detection of glycoconjugates by mass spectrometry imaging and microscopy. | Methods Enzymol | 2026 | 42349971 | PubTator, text mining | PubMed |
| Galacto-Oligosaccharides Reshape Mucin O-Glycan Profiles to Enhance Small Intestinal Barrier Development in Early Life. | J Agric Food Chem | 2026 | 42284521 | PubTator, text mining | PubMed |
| Rab11Bis required for binding and entry of recent H3N2, but not H1N1, influenza A isolates. | J Virol | 2026 | 42227759 | PubTator, text mining | PubMed |
| Siglec-G on B cells restrains the germinal center response by controlling T cell help during positive selection. | bioRxiv | 2026 | 42182281 | PubTator, text mining | PubMed |
| Blood transcriptomic signatures distinguish Mycobacterium avium complex pulmonary disease from colonization: a multicenter cohort study. | Emerg Microbes Infect | 2026 | 42175713 | PubTator, text mining | PubMed |
| Severe hypoxia drives loss of ST6GAL1-mediated α2,6-sialylation in the epicardial secretome impairing angiogenic activity. | Biol Open | 2026 | 42052876 | PubTator, text mining | PubMed |
1 to 10 of 1,381
See all 1,381 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/28906
GET https://conductscience.org/api/genes/v1/28906/grants?page=2